| 中文别名： |
(-)-2-氰基-6-苯恶唑并吡啶;(-)-2-Cyano-6-phenyloxazolopiperidine (-)-2-氰基-6-苯恶唑并吡啶;(-)-2-氰-6-苯基恶唑哌啶;(1R,2S,5R)-(-)-薄荷基 (S)-对甲苯亚磺酸酯;(3R,5S,8aR)-(-)-六氢-3-苯基-5H-噁唑[3,2-a]吡啶-5-甲腈;(3R,5S,8AR)-3-苯基六氢-5H-[1,3]恶唑并[3,2-A]吡啶-5-甲腈;(-)-2-氰基-6-苯基噁唑哌啶;[3R-(3α,5β,8aβ)]-六氢-3-苯基-5H-噁唑并[3,2-a]吡啶-5-甲腈;(3R,5S,8aR)-3-苯基六氢-5H-[1,3]恶唑并[3,2-a]吡啶-5-甲腈 |
| 英文别名： |
5H-Oxazolo[3,2-a]pyridine-5-carbonitrile,hexahydro-3-phenyl-, (3R,5S,8aR)-;(-)-2-Cyano-6-phenyloxazolopiperidine;(3R,5S,8aR)-(?)-Hexahydro-3-phenyl-5H-oxazolo[3,2-a]pyridine-5-carbonitrile;(3R,5S,8aR)-3-phenylhexahydro-5H-[1,3]oxazolo[3,2-a]pyridine-5-carbonitrile;(-)-5-Cyano-3-phenyl-2,3,5,6,7,8-hexahydro-5H-oxazolo[3,2-a]pyridine;(-)-2,3,5,6,7,8-Hexahydro-3-phenyl-5H-oxazolo[3,2-a]pyridine-5-carbonitrile;(3R,5S,8AR)-3-phenylhexahydro-2H-oxazolo[3,2-a]pyridine-5-carbonitrile;AS-72663;SCHEMBL2882752;(3R,5S,8aR)-(-)-Hexahydro-3-phenyl-5H-oxazolo[3,2-a]pyridine-5-carbonitrile, 97%;(3R,5S,8aR)-(-)-Hexahydro-3-phenyl-5H-oxazolo[3,2-a]pyridine-5-carbonitrile;88056-92-2;C1363;(2S,6R,9R)-9-phenyl-7-oxa-1-azabicyclo[4.3.0]nonane-2-carbonitrile;AKOS005256850;(3R,5S,8aR)-3-Phenylhexahydro-5H-[1,3]oxazolo[3,2-a]pyridine-5-carbonitrile;T71426;(3R,5S,8AR)-3-PHENYL-HEXAHYDRO-2H-[1,3]OXAZOLO[3,2-A]PYRIDINE-5-CARBONITRILE;(3R,5S,8aR)-3-phenyl-3,5,6,7,8,8a-hexahydro-2H-[1,3]oxazolo[3,2-a]pyridine-5-carbonitrile |
沪公网安备 
